Metabolites
Displaying compounds 3776 - 3800 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12563 | CDP-DG(22:0/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(9Z)-tetracos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H107N3O15P2 1148.448 | |
| YMDB12562 | CDP-DG(22:0/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(11Z)-tetracos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H107N3O15P2 1148.448 | |
| YMDB12561 | CDP-DG(22:0/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-(tetracosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H109N3O15P2 1150.464 | |
| YMDB12560 | CDP-DG(22:0/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H105N3O15P2 1134.421 | |
| YMDB12559 | CDP-DG(22:0/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H105N3O15P2 1134.421 | |
| YMDB12558 | CDP-DG(22:0/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-docos-9-enoyloxy]-3-(docosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
| YMDB12557 | CDP-DG(22:0/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(docosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
| YMDB12556 | CDP-DG(22:0/22:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis(docosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H105N3O15P2 1122.41 | |
| YMDB12555 | CDP-DG(20:1(13Z)/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-(triacontanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12554 | CDP-DG(20:1(13Z)/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(10Z)-octacos-10-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12553 | CDP-DG(20:1(13Z)/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(12Z)-octacos-12-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12552 | CDP-DG(20:1(13Z)/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-(octacosanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C60H111N3O15P2 1176.502 | |
| YMDB12551 | CDP-DG(20:1(13Z)/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12550 | CDP-DG(20:1(13Z)/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12549 | CDP-DG(20:1(13Z)/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12548 | CDP-DG(20:1(13Z)/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(10Z)-heptacos-10-enoyloxy]-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12547 | CDP-DG(20:1(13Z)/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(12Z)-hexacos-12-enoyloxy]-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12546 | CDP-DG(20:1(13Z)/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(hexacosanoyloxy)-3-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H107N3O15P2 1148.448 | |
| YMDB12545 | CDP-DG(20:1(13Z)/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(9Z)-pentacos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C57H103N3O15P2 1132.405 | |
| YMDB12544 | CDP-DG(20:1(13Z)/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(11Z)-pentacos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C57H103N3O15P2 1132.405 | |
| YMDB12543 | CDP-DG(20:1(13Z)/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-(pentacosanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C57H105N3O15P2 1134.421 | |
| YMDB12542 | CDP-DG(20:1(13Z)/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(9Z)-tetracos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C56H101N3O15P2 1118.378 | |
| YMDB12541 | CDP-DG(20:1(13Z)/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(11Z)-tetracos-11-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C56H101N3O15P2 1118.378 | |
| YMDB12540 | CDP-DG(20:1(13Z)/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-(tetracosanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
| YMDB12539 | CDP-DG(20:1(13Z)/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(13Z)-icos-13-enoyloxy]-2-[(9Z)-tricos-9-enoyloxy]propoxy]phosphoryl}oxy)phosphinic acid | C55H99N3O15P2 1104.351 |